ZYPPAH, with a valuation of $25 million, is raising funds on Dealmaker Securities. The company makes its patented mouthguards to solve the problem of snoring. ZYPPAH mouthguards directly stop the tongue from blocking the airway and have demonstrated a 91% success rate in resolving snoring problems in an FDA-approved clinical study. The business has sold over 500,000 units of mouthguards to more than 400,000 customers and generated $55 million in sales. Jonathan Greenburg founded ZYPPAH in March 2012. The current crowdfunding campaign has a minimum target of $10,300 and a maximum target of $1.1 million. The campaign proceeds will be used for manufacturing, operational costs, and marketing.